| United States |
84 |
-
Summit Therapeutics Inc. (aktie - 2.39%)
-
IGM Biosciences, Inc. (aktie - 1.61%)
-
Longboard Pharmaceuticals, Inc. (aktie - 1.34%)
-
Viridian Therapeutics, Inc. (aktie - 1.34%)
-
AnaptysBio, Inc. (aktie - 1.26%)
-
Edgewise Therapeutics, Inc. (aktie - 1.25%)
-
Vaxcyte, Inc. (aktie - 1.23%)
-
Arcellx, Inc. (aktie - 1.23%)
-
Nurix Therapeutics, Inc. (aktie - 1.21%)
-
Cassava Sciences, Inc. (aktie - 1.19%)
-
ORIC Pharmaceuticals, Inc. (aktie - 1.16%)
-
Applied Therapeutics (aktie - 1.16%)
-
Kymera Therapeutics, Inc. (aktie - 1.13%)
-
Denali Therapeutics Inc. (aktie - 1.11%)
-
Protagonist Therapeutics, Inc. (aktie - 1.09%)
-
Nuvalent, Inc. (aktie - 1.08%)
-
Viking Therapeutics, Inc. (aktie - 1.07%)
-
Erasca, Inc. (aktie - 1.05%)
-
Terns Pharmaceuticals, Inc. (aktie - 0.9945%)
-
Disc Medicine Opco Inc (aktie - 0.9727%)
-
Janux Therapeutics, Inc. (aktie - 0.9395%)
-
Annexon, Inc. (aktie - 0.9266%)
-
Alector, Inc. (aktie - 0.9238%)
-
Replimune Group, Inc. (aktie - 0.913%)
-
Vera Therapeutics, Inc. (aktie - 0.9061%)
-
Revolution Medicines, Inc. (aktie - 0.9058%)
-
Akero Therapeutics, Inc. (aktie - 0.9026%)
-
Celldex Therapeutics, Inc. (aktie - 0.8962%)
-
Crinetics Pharmaceuticals, Inc. (aktie - 0.8961%)
-
Keros Therapeutics, Inc. (aktie - 0.8913%)
-
CG Oncology, Inc. (aktie - 0.8874%)
-
Avidity Biosciences, Inc. (aktie - 0.881%)
-
Savara Inc. (aktie - 0.8758%)
-
Allogene Therapeutics (aktie - 0.873%)
-
Immunovant, Inc. (aktie - 0.8695%)
-
Olema Pharmaceuticals, Inc. (aktie - 0.8666%)
-
Arcutis Biotherapeutics (aktie - 0.8606%)
-
Dyne Therapeutics, Inc. (aktie - 0.8602%)
-
Enliven Therapeutics, Inc. (aktie - 0.8345%)
-
Cytokinetics, Incorporated (aktie - 0.8072%)
-
Beam Therapeutics Inc. (aktie - 0.8051%)
-
Pliant Therapeutics, Inc. (aktie - 0.8029%)
-
Scholar Rock Holding Corporation (aktie - 0.7884%)
-
Xencor, Inc. (aktie - 0.7827%)
-
Kura Oncology, Inc. (aktie - 0.7696%)
-
Arcus Biosciences, Inc. (aktie - 0.7681%)
-
Arvinas, Inc. (aktie - 0.7677%)
-
Belite Bio, Inc (aktie - 0.7671%)
-
Celcuity Inc. (aktie - 0.7664%)
-
Relay Therapeutics, Inc. (aktie - 0.7592%)
-
Nuvation Bio Inc. (aktie - 0.7415%)
-
Immunome (aktie - 0.7397%)
-
Verve Therapeutics, Inc. (aktie - 0.7338%)
-
Mineralys Therapeutics, Inc. (aktie - 0.7312%)
-
IDEAYA Biosciences, Inc. (aktie - 0.7125%)
-
REGENXBIO (aktie - 0.7075%)
-
Syndax Pharmaceuticals, Inc. (aktie - 0.6988%)
-
89bio, Inc. (aktie - 0.6983%)
-
Rocket Pharmaceuticals, Inc. (aktie - 0.6981%)
-
Intellia Therapeutics, Inc. (aktie - 0.6674%)
-
Cullinan Oncology, Inc. (aktie - 0.6594%)
-
Arrowhead Pharmaceuticals, Inc. (aktie - 0.6216%)
-
Stoke Therapeutics, Inc. (aktie - 0.621%)
-
Vir Biotechnology, Inc. (aktie - 0.5931%)
-
Liquidia Corporation (aktie - 0.5865%)
-
Larimar Therapeutics, Inc. (aktie - 0.5776%)
-
Recursion Pharmaceuticals, Inc. (aktie - 0.5705%)
-
MacroGenics, Inc. (aktie - 0.5551%)
-
iTeos Therapeutics, Inc. (aktie - 0.5471%)
-
Editas Medicine, Inc. (aktie - 0.5439%)
-
Arcturus Therapeutics Holdings Inc. (aktie - 0.5169%)
-
Sana Biotechnology, Inc. (aktie - 0.4707%)
-
Precigen, Inc. (aktie - 0.4635%)
-
Lyell Immunopharma, Inc. (aktie - 0.4617%)
-
Taysha Gene Therapies, Inc. (aktie - 0.4083%)
-
4D Molecular Therapeutics, Inc. (aktie - 0.3858%)
-
Prime Medicine, Inc. (aktie - 0.3841%)
-
Zentalis Pharmaceuticals, Inc. (aktie - 0.3511%)
-
Fulcrum Therapeutics, Inc. (aktie - 0.3411%)
-
Cabaletta Bio, Inc. (aktie - 0.2964%)
-
ALX Oncology Holdings Inc. (aktie - 0.1942%)
-
Scilex Holding Company (aktie - 0.1466%)
-
HilleVax, Inc. (aktie - 0.0964%)
-
Aerovate Therapeutics, Inc. (aktie - 0.0612%)
|
